Skip to main content
Due to weather conditions, our Mansfield Urgent Care location is closed. If you need medical care for your child, please take him or her to the nearest emergency room.
Go to homepage

Perampanel in Children 1 month to 2 years

Safety and Efficacy of Perampanel in Children 1 month to 2 years


For complete study information, please view the study on

Interested in participating?
We are currently recruiting
Full IRB Study Title:
An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 24 Months (<2 years) of Age With Epilepsy
IRB Study ID:
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email
Lead Investigator
Michael Kohrman, MD

Director, Pediatric Neurology; Co-director, Tuberous Sclerosis Program; Pediatric Neurologist
Pediatric Epilepsy ProgramPediatric NeurologyTuberous Sclerosis ClinicNeuroDevelopmental Science CenterPediatric Sleep Center